Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,940.00
Bid: 1,940.00
Ask: 1,942.00
Change: 5.00 (0.26%)
Spread: 2.00 (0.103%)
Open: 1,938.00
High: 1,942.00
Low: 1,926.00
Prev. Close: 1,935.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 14th Feb 2013 08:09

African Barrick Gold: Deutsche Bank cuts target price from 410p to 340p, while staying with its hold recommendation. Investec reduces target price from 405p to 315p and downgrades from buy to hold. JP Morgan lowers target price from 370p to 290p and downgrades to underweight.AG Barr: Barclays downgrades to equal-weight. Canaccord Genuity downgrades to hold with a target price of 490p.ASOS: HSBC raises target price from 2750p to 3530p and upgrades to overweight.Barclays: Deutsche Bank revises target price from 360p to 380p maintaining a buy recommendation. Investec moves target price from 320p to 340p, while downgrading from buy to hold.Brown (N) Group: HSBC takes target price from 420p to 430p reiterating an overweight rating.Britvic: Barclays cuts to equal-weight. JP Morgan lowers target price from 400p to 380p and downgrades to underperform.Daily Mail and General Trust: UBS raises target price from 520p to 650p maintaining a neutral rating.Euromoney Institutional Investor: UBS increases target price from 775p to 900p and retains a neutral rating.FlyBe: HSBC lowers target price from 80p to 70p and retains an overweight rating.Gulfsands Petroleum: Cantor Fitzgerald (formerly Seymour Pierce) reduces target price from 366p to 162p and keeps a buy recommendation.G4S: Investec revises target price from 280p to 330p and upgrades from hold to buy.Halma: Investec increases target price from 515p to 550p keeping a buy recommendation.Hikma: Panmure Gordon ups target price from 825p to 930p, while leaving its buy recommendation unchanged.JSC Bank of Georgia Holdings: Citigroup downgrades to neutral with a target price of 1500p.Laird: JP Morgan moves target price from 281p to 291p reiterating an overweight rating. Numis increases target price from 250p to 310p and stays with its buy recommendation.McBride: Investec shifts target price from 150p to 154p and maintains a buy rating.Morgan Crucible: Investec ups target price from 295p to 370p and leaves its buy recommendation unchanged.Newmark Security: Cantor Fitzgerald (formerly Seymour Pierce) moves target price from 1.50p to 2.00p maintaining a buy recommendation.Next: HSBC increases target price from 4100p to 4965p upgrading to overweight.Norcros: Numis downgrades to add with a target price of 20p.Oxford Instruments: JP Morgan takes target price from 1500p to 1750p and leaves its overweight rating unchanged.Reckitt Benckiser: Deutsche Bank ups target price from 4600p to 4800p and stays with its buy recommendation. Credit Suisse raises target price from 3700p to 4000p retaining a neutral rating. Nomura increases target price from 4800p to 4900p, while its buy recommendation is kept. Oriel Securities moves target price from 3730p to 4700p upgrading to add.Rolls-Royce Group: Investec downgrades from buy to add with its target price at 1005p.Salamander Energy: Investec revises target price from 200p to 250p and upgrades from hold to buy.SOCO International: Exane BNP lowers target price from 405p to 390p, while leaving its neutral rating unaltered.Spirent Communications: Panmure Gordon shifts target price from 184p to 192p and keeps a buy recommendation.SVG Capital: Oriel Securities shifts target price from 360p to 370p, while its buy recommendation is kept.Synergy Health: Investec raises target price from 1048p to 1105p, while downgrading from buy to add.Telecity Group: Investec ups target price from 750p to 1000p and upgrades from hold to buy. UBS revises target price from 945p to 1000p reiterating a buy recommendation.Tullow Oil: Deutsche Bank reduces target price from 1105p to 1075p keeping a hold recommendation. Credit Suisse cuts target price from 1450p to 1350p, while its neutral rating remains unchanged. Nomura lowers target price from 1350p to 1330p and retains a reduce rating.Whitbread: Investec increases target price from 1650p to 2000p, but still recommends selling.
More News
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more
3 Nov 2022 09:18

LONDON MARKET OPEN: BT results disappoint; pound falls on Fed outlook

(Alliance News) - Stock prices in London opened lower on Thursday, as the pound fell against a strengthening dollar, after the Federal Reserve indicated that US interest rates are likely to reach higher levels than previously thought.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.